Drug Trial Radar · NCT06701526
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
164
Actual
Start
Dec 18, 2024
Primary completion
Sep 2, 2026
Study completion Sep 2, 2026
Sponsor
- Lead sponsor
- H. Lundbeck A/SIndustry
- Sponsor type
- Industry
- First posted
- Nov 22, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not perceive a sufficient improvement during previous treatment with therapies targeting calcitonin gene-related peptide (CGRP).
Conditions
- Migraine
Interventions
EptinezumabDrug
Solution for infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Response of "Much Improved" or "Very Much Improved" on the Patient Global Impression of Change (PGIC) ScaleTime frame: Week 24
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
St. Joseph's Hospital and Medical Center-Barrow Neurological Institute - Barrow Brain Tumor Resea...
Phoenix, Arizona
Mayo Clinic - Vascular Center - Arizona
Phoenix, Arizona
Baptist Health Center for Clinical Research (BHCCR)
Little Rock, Arkansas
The Neuron Clinic - Escondido
San Marcos, California
Sunwise Clinical Research, LLC
Walnut Creek, California
Hasbani Neurology - New Haven
New Haven, Connecticut
New England Institute for Neurology and Headache (NEINH) - Stamford
Stamford, Connecticut
Brainstorm Research, Inc.
Miami, Florida
Chicago Headache Center and Research Institute - Chicago
Chicago, Illinois
Crescent City Headache and Neurology Center
Chalmette, Louisiana
Neurology Center of New England, PC
Foxborough, Massachusetts
Mass Institute of Clinical Research
Westborough, Massachusetts
Michigan Headache & Neurological Institute (MHNI)
Ann Arbor, Michigan
Albany Medical College
Albany, New York
Dent Neurosciences Research Center
Amherst, New York
North Suffolk Neurology - Port Jefferson Station
Port Jefferson Station, New York
Headache Wellness Center
Greensboro, North Carolina
C7 Research
Cleveland, Ohio
Thomas Jefferson University Hospital - Breast Care Center
Philadelphia, Pennsylvania
Preferred Primary Care Physicians - Pleasant Hills - Curry Hollow Road
Pittsburgh, Pennsylvania
KCA Neurology, PLLC
Franklin, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.